Health TrialsbyHealthPanel

Predictive and Diagnostic Value of BIND Score in Assessment of Severe Neonatal Jaundice Cases in Neonatal Intensive Care Unit

ConditionNeonatal Hyperbilirubinemia
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-28
SponsorAssiut University

About this trial

Early detection and prevention of neonatal encephalopathy using BIND score.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

Neonates with severe neonatal jaundice

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Phototherapy

    Device

    Phototherapy used to decrease high billirubin level in neonatal jaundice

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Decrease high billirubin level

We use bind score to evaluate neurological condition of neoborns then use photo therapy to decrease

Time frame
One year duration
2

Predictive and diagnostic value of BIND score in assessment of severe neonatal jaundice cases in NICU

Early detection and prevention of neonatal encephalopathy using BIND score.

Time frame
Baseline
3

Predictive and diagnostic value of BIND score in assessment of severe neonatal jaundice cases in NICU

Time frame
Baseline

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Assiut University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: